Metabolic Reprogramming in Melanoma: An Epigenetic Point of View
Sandro Giuliani(Istituti di Ricovero e Cura a Carattere Scientifico), Italia Falcone(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 10
Related Papers
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations
|International Journal of Molecular Sciences|2025|0